Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
155.00    0.00 (0.00%)
Bid:
150.00
Ask:
160.00
Spread: 10.00 (6.667%)
Market Cap: £205.95m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Investor Presentation

15 Nov 2024 08:30

RNS Number : 4206M
AdvancedAdvT Limited
15 November 2024
 

15 November 2024

 

AdvancedAdvT Limited

 

Investor Presentation

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business, compliance, and resource management, is pleased to announce that Vin Murria and Gavin Hugill will provide a live presentation relating to the Investor Presentation via Investor Meet Company on 19 Nov 2024, 10:30 GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 18 Nov 2024, 09:00 GMT, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet AdvancedAdvT Limited via:

 

https://www.investormeetcompany.com/advancedadvt-limited/register-investor

 

Investors who already follow AdvancedAdvT Limited on the Investor Meet Company platform will automatically be invited.

 

 

Enquiries:

 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

Meare Consulting 

Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

 

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software), WFM (workforce management software provider) and Celaton, a machine-learning AI based intelligent process automation ("IPA") platform (inSTREAM).

 

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVAWRSUUAARA
Date   Source Headline
1st Aug 20237:00 amRNSCompletion of Acquisitions
28th Jul 20237:00 amRNSAudited results for the year ended 30 June 2023
5th Jul 20236:05 pmRNSResult of AGM
9th Jun 20233:31 pmRNSNotice of AGM
8th Jun 20237:35 amRNSAcquisitions and Suspension of Listing
8th Jun 20237:30 amRNSSuspension - AdvancedAdvT Limited
24th May 20231:18 pmRNSHolding(s) in Company
5th May 20231:21 pmRNSHolding(s) in Company
20th Apr 202311:19 amRNSHolding(s) in Company
29th Mar 20233:49 pmRNSHolding(s) in Company
15th Mar 20232:46 pmRNSHolding(s) in Company
14th Mar 20237:00 amRNSInterim Results
1st Mar 20235:07 pmRNSHolding(s) in Company
21st Feb 20239:11 amRNSHolding(s) in Company
21st Feb 20239:10 amRNSDirector/PDMR Shareholding
6th Jan 202310:02 amRNSHolding(s) in Company
6th Jan 202310:01 amRNSHolding(s) in Company
6th Jan 20239:52 amRNSDirector/PDMR Shareholding
2nd Dec 20222:19 pmRNSHolding(s) in Company
2nd Dec 20222:15 pmRNSHolding(s) in Company
30th Nov 20221:22 pmRNSDirector/PDMR Shareholding
19th Oct 20222:44 pmRNSForm 8.3 - NEXT FIFTEEN COMMUNICATIONS GROUP PLC
18th Oct 20222:09 pmRNSHolding(s) in Company
14th Oct 202210:38 amRNSFinal Results
4th Oct 20228:56 amRNSForm 8.5 (EPT/RI) - Advancedadvt Limited
3rd Oct 202210:19 amRNSForm 8.5 (EPT/RI)
30th Sep 20225:26 pmRNSLapse of ADV Offer
30th Sep 20224:34 pmRNSOffer Lapsed
30th Sep 20221:56 pmRNSForm 8.3 - AdvancedAdvT Ltd
30th Sep 202210:33 amRNSRule 8.3 - ADVT
30th Sep 20229:17 amRNSForm 8.5 (EPT/RI)
30th Sep 20227:00 amRNSUpdate on Acceptance Levels
29th Sep 20222:07 pmRNSForm 8.3 - M&C SAATCHI
29th Sep 202212:18 pmRNSRule 8.3- ADVT
29th Sep 202210:50 amRNSForm 8.3 - AdvancedAdvT
29th Sep 202210:44 amRNSForm 8.5 (EPT/RI)
29th Sep 20227:00 amRNSUpdate on Acceptance Levels
28th Sep 202210:21 amRNSForm 8.5 (EPT/RI)
28th Sep 20229:49 amGNWRule 8.3 - AdvancedAdvt Limited
28th Sep 20227:00 amRNSUpdate on Acceptance Levels
27th Sep 20224:19 pmRNSPublication of Supplemental Prospectus
27th Sep 20227:00 amRNSUpdate on Acceptance Levels
26th Sep 20222:19 pmRNSRule 8.3- ADVT
26th Sep 20221:51 pmRNSADV Acceptance Levels and Rejection of ADV Offer
26th Sep 202211:44 amRNSForm 8.5 (EPT/RI)
26th Sep 202210:36 amGNWRule 8.3 - AdvancedAdvT Limited
26th Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
22nd Sep 20227:00 amRNSUpdate on Acceptance Levels

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.